Performance of standardized cancer patient pathways in Sweden visualized using observational data and a state-transition model

被引:1
作者
Borg, Sixten [1 ,2 ]
Horstedt, Ann-Sofi [1 ]
Carlsson, Tobias [1 ]
Nilbert, Mef [1 ,3 ]
Larsson, Anna-Maria [1 ,3 ]
Ohlsson, Bjorn [1 ,4 ]
机构
[1] RCC Syd, Reg Canc Ctr South, Scheelevagen 8, S-22381 Lund, Sweden
[2] Lund Univ, Dept Clin Sci Malmo, Hlth Econ Unit, Lund, Sweden
[3] Lund Univ, Skane Univ Hosp, Div Oncol, Dept Clin Sci, Lund, Sweden
[4] Blekinge Hosp, Dept Surg, Karlshamn, Sweden
来源
SCIENTIFIC REPORTS | 2023年 / 13卷 / 01期
关键词
D O I
10.1038/s41598-023-46757-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Standardized Cancer Patient Pathways (CPPs) were introduced in Swedish healthcare starting in 2015 to improve diagnostics for patients with symptoms of cancer, patient satisfaction and equity of care between healthcare providers. An inclusion target and a time target were set. Our primary aim was to visualize the patient population going through CPPs, in terms of investigation time and indications of the various outcomes including cancer diagnoses. Our secondary aims were to examine if targets were met, and to examine frequencies of undetected cancer. We collected data from 19,204 patients starting in a CPP, and 7895 patients diagnosed with cancer in 2018 in a region of Sweden. A state transition model was developed and used as analytical framework, and patients were mapped over time in the states of the model. Visualization of the patient-flow through the model illustrates speed of investigation, time to treatment, frequencies of detected and undetected cancer. Twelve CPPs out of 28 met the inclusion target, five met the time target. After suspicion of cancer rejected, 0.8% of patients were diagnosed with the primarily suspected cancer, 1.0% with another cancer. In patients not meeting the criteria for well-founded suspicion less than 3% were later diagnosed with cancer. The visualization of the patient flow into and through standardized cancer patient pathways illustrates investigation time, events occurring and outcomes. The use of standardized cancer patient pathways detects cancer efficiently.
引用
收藏
页数:12
相关论文
共 21 条
  • [1] Shared decision-making in standardized cancer patient pathways in Norway-Narratives of patient experiences
    Andersen-Hollekim, Tone
    Melby, Line
    Sand, Kari
    Gilstad, Heidi
    Das, Anita
    Solbjor, Marit
    [J]. HEALTH EXPECTATIONS, 2021, 24 (05) : 1780 - 1789
  • [2] A Maximum Likelihood Estimator of a Markov Model for Disease Activity in Crohn's Disease and Ulcerative Colitis for Annually Aggregated Partial Observations
    Borg, Sixten
    Persson, Ulf
    Jess, Tine
    Thomsen, Ole Ostergaard
    Ljung, Tryggve
    Riis, Lene
    Munkholm, Pia
    [J]. MEDICAL DECISION MAKING, 2010, 30 (01) : 132 - 142
  • [3] Collaboration of Regional Cancer Centres, Shorter Waiting Times in Cancer Care-Status for Inclusion Target and Lead Time Target in Standardized Cancer Patient Pathways
  • [4] Collaboration of Regional Cancer Centres, Statistics on Standardized Cancer Patient Pathways
  • [5] Use and diagnostic outcomes of cancer patient pathways in Denmark - is the place of initial diagnostic work-up an important factor?
    Damhus, Christina Sadolin
    Siersma, Volkert
    Birkmose, Anna Rubach
    Dalton, Susanne Oksbjerg
    Brodersen, John
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [6] Implementing standardized cancer patient pathways (CPPs) - a qualitative study exploring the perspectives of health care professionals
    Delilovic, Sara
    Hasson, Henna
    Ahstrom, Marten
    von Knorring, Mia
    [J]. BMC HEALTH SERVICES RESEARCH, 2019, 19 (01)
  • [7] Ejven A., 2022, The Effect of Patient Pathway for Colorectal Cancer on Treatment Costs in Norway
  • [8] GPs' perspectives of the patient encounter - in the context of standardized cancer patient pathways
    Hultstrand, Cecilia
    Coe, Anna-Britt
    Lilja, Mikael
    Hajdarevic, Senada
    [J]. SCANDINAVIAN JOURNAL OF PRIMARY HEALTH CARE, 2020, 38 (02) : 238 - 247
  • [9] Open Access The Danish cancer pathway for patients with serious non-specific symptoms and signs of cancer-a cross-sectional study of patient characteristics and cancer probability
    Ingeman, Mads Lind
    Christensen, Morten Bondo
    Bro, Flemming
    Knudsen, Soren T.
    Vedsted, Peter
    [J]. BMC CANCER, 2015, 15
  • [10] Knudsen J.L., 2017, Health Systems Improvement Across the Globe: Success Stories from 60 Countries, P133